140 related articles for article (PubMed ID: 16144797)
41. Association between the prevalence of antibodies to beta(2)-glycoprotein I, prothrombin, protein C, protein S, and annexin V in patients with systemic lupus erythematosus and thrombotic and thrombocytopenic complications.
Nojima J; Kuratsune H; Suehisa E; Futsukaichi Y; Yamanishi H; Machii T; Iwatani Y; Kanakura Y
Clin Chem; 2001 Jun; 47(6):1008-15. PubMed ID: 11375285
[TBL] [Abstract][Full Text] [Related]
42. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
43. Specificity and sensitivity of anti-beta2-glycoprotein I as compared with anticardiolipin antibody and lupus anticoagulant in Thai systemic lupus erythematosus patients with clinical features of antiphospholipid syndrome.
Parkpian V; Verasertniyom O; Vanichapuntu M; Totemchokchyakarn K; Nantiruj K; Pisitkul P; Angchaisuksiri P; Archararit N; Rachakom B; Ayurachai K; Janwityanujit S
Clin Rheumatol; 2007 Oct; 26(10):1663-70. PubMed ID: 17332980
[TBL] [Abstract][Full Text] [Related]
44. The role of clinically significant antiphospholipid antibodies in systemic lupus erythematosus.
Taraborelli M; Lazzaroni MG; Martinazzi N; Fredi M; Cavazzana I; Franceschini F; Tincani A
Reumatismo; 2016 Dec; 68(3):137-143. PubMed ID: 27981815
[TBL] [Abstract][Full Text] [Related]
45. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
Arnoux D; Boutière B; Sanmarco M
Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
[TBL] [Abstract][Full Text] [Related]
46. Transiently positive anticardiolipin antibodies and risk of thrombosis in patients with systemic lupus erythematosus.
Martinez-Berriotxoa A; Ruiz-Irastorza G; Egurbide MV; Garmendia M; Gabriel Erdozain J; Villar I; Aguirre C
Lupus; 2007; 16(10):810-6. PubMed ID: 17895304
[TBL] [Abstract][Full Text] [Related]
47. Prophylactic antithrombotic therapy for patients with systemic lupus erythematosus with or without antiphospholipid antibodies: do the benefits outweigh the risks? A decision analysis.
Wahl DG; Bounameaux H; de Moerloose P; Sarasin FP
Arch Intern Med; 2000 Jul; 160(13):2042-8. PubMed ID: 10888978
[TBL] [Abstract][Full Text] [Related]
48. Antibodies to age-β2 glycoprotein I in patients with anti-phospholipid antibody syndrome.
Sorice M; Buttari B; Capozzi A; Profumo E; Facchiano F; Truglia S; Recalchi S; Alessandri C; Conti F; Misasi R; Valesini G; Riganò R
Clin Exp Immunol; 2016 May; 184(2):174-82. PubMed ID: 26702877
[TBL] [Abstract][Full Text] [Related]
49. Strong correlation between the prevalence of cerebral infarction and the presence of anti-cardiolipin/beta2-glycoprotein I and anti-phosphatidylserine/prothrombin antibodies--Co-existence of these antibodies enhances ADP-induced platelet activation in vitro.
Nojima J; Kuratsune H; Suehisa E; Kitani T; Iwatani Y; Kanakura Y
Thromb Haemost; 2004 May; 91(5):967-76. PubMed ID: 15116258
[TBL] [Abstract][Full Text] [Related]
50. Update on anti-phospholipid antibodies in SLE: the Hopkins' Lupus Cohort.
Petri M
Lupus; 2010 Apr; 19(4):419-23. PubMed ID: 20353980
[TBL] [Abstract][Full Text] [Related]
51. [Relationship between phenomenon of acquired activated protein C resistance and antiphospholipid antibodies in patients with systemic lupus erythematosus].
Hu YQ; Chen FP; Xie QZ
Hunan Yi Ke Da Xue Xue Bao; 2001 Oct; 26(5):469-72. PubMed ID: 12536506
[TBL] [Abstract][Full Text] [Related]
52. Antiphospholipid antibodies in pediatric systemic lupus erythematosus.
Seaman DE; Londino AV; Kwoh CK; Medsger TA; Manzi S
Pediatrics; 1995 Dec; 96(6):1040-5. PubMed ID: 7491218
[TBL] [Abstract][Full Text] [Related]
53. Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study.
Saccone G; Berghella V; Maruotti GM; Ghi T; Rizzo G; Simonazzi G; Rizzo N; Facchinetti F; Dall'Asta A; Visentin S; Sarno L; Xodo S; Bernabini D; Monari F; Roman A; Eke AC; Hoxha A; Ruffatti A; Schuit E; Martinelli P;
Am J Obstet Gynecol; 2017 May; 216(5):525.e1-525.e12. PubMed ID: 28153662
[TBL] [Abstract][Full Text] [Related]
54. Novel enzyme immunoassay system for simultaneous detection of six subclasses of antiphospholipid antibodies for differential diagnosis of antiphospholipid syndrome.
Nojima J; Motoki Y; Hara K; Sakata T; Ichihara K
Blood Coagul Fibrinolysis; 2017 Jun; 28(4):316-322. PubMed ID: 27676644
[TBL] [Abstract][Full Text] [Related]
55. Arteriosclerosis obliterans associated with anti-cardiolipin antibody/beta2-glycoprotein I antibodies as a strong risk factor for ischaemic heart disease in patients with systemic lupus erythematosus.
Nojima J; Masuda Y; Iwatani Y; Kuratsune H; Watanabe Y; Suehisa E; Takano T; Hidaka Y; Kanakura Y
Rheumatology (Oxford); 2008 May; 47(5):684-9. PubMed ID: 18375400
[TBL] [Abstract][Full Text] [Related]
56. Antiphospholipid antibodies in arterial thrombosis.
Koike T
Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
[TBL] [Abstract][Full Text] [Related]
57. Thrombotic Primary Antiphospholipid Syndrome: the profile of antibody positivity in patients from North India.
Ahluwalia J; Sreedharanunni S; Kumar N; Masih J; Bose SK; Varma N; Varma S; Singh S
Int J Rheum Dis; 2016 Sep; 19(9):903-12. PubMed ID: 25292011
[TBL] [Abstract][Full Text] [Related]
58. Antiphospholipid antibodies--we are not quite there yet.
Urbanus RT; de Groot PG
Blood Rev; 2011 Mar; 25(2):97-106. PubMed ID: 21242018
[TBL] [Abstract][Full Text] [Related]
59. Prevalence and clinical significance of antiphospholipid antibodies to noncardiolipin antigens in systemic lupus erythematosus.
Toschi V; Motta A; Castelli C; Gibelli S; Cimminiello C; Molaro GL; Gibelli A
Haemostasis; 1993; 23(5):275-83. PubMed ID: 8175049
[TBL] [Abstract][Full Text] [Related]
60. Elevated partial antiphospholipid score is a strong risk factor for thrombosis in patients with systemic lupus erythematosus: a validation study.
Chen J; Sun S; Yan Q; Bao C; Fu Q
Clin Rheumatol; 2016 Feb; 35(2):333-40. PubMed ID: 26753544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
